Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$242.49 - $301.46 $17.1 Million - $21.2 Million
-70,474 Reduced 88.0%
9,614 $2.36 Million
Q2 2022

Aug 15, 2022

BUY
$224.73 - $338.64 $13.1 Million - $19.7 Million
58,173 Added 265.45%
80,088 $19.8 Million
Q1 2022

May 16, 2022

BUY
$277.25 - $366.29 $2.79 Million - $3.69 Million
10,068 Added 84.98%
21,915 $7.26 Million
Q4 2021

Feb 14, 2022

SELL
$300.63 - $371.35 $7.86 Million - $9.71 Million
-26,137 Reduced 68.81%
11,847 $4.26 Million
Q3 2021

Nov 15, 2021

SELL
$310.19 - $376.2 $7.09 Million - $8.6 Million
-22,847 Reduced 37.56%
37,984 $12.4 Million
Q2 2021

Aug 16, 2021

BUY
$262.71 - $351.17 $10.8 Million - $14.4 Million
41,031 Added 207.23%
60,831 $19 Million
Q1 2021

May 17, 2021

BUY
$285.92 - $355.13 $4.15 Million - $5.15 Million
14,513 Added 274.5%
19,800 $6.31 Million
Q4 2020

Feb 16, 2021

SELL
$251.88 - $324.2 $2.5 Million - $3.22 Million
-9,937 Reduced 65.27%
5,287 $1.71 Million
Q3 2020

Nov 16, 2020

BUY
$255.22 - $317.0 $3.17 Million - $3.93 Million
12,408 Added 440.63%
15,224 $4.22 Million
Q2 2020

Aug 14, 2020

BUY
$141.4 - $257.09 $79,466 - $144,484
562 Added 24.93%
2,816 $680,000
Q1 2020

May 14, 2020

SELL
$130.51 - $196.01 $31 Million - $46.5 Million
-237,386 Reduced 99.06%
2,254 $327,000
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $30.4 Million - $42.6 Million
190,659 Added 389.25%
239,640 $40.9 Million
Q3 2019

Nov 14, 2019

SELL
$175.89 - $279.23 $4.38 Million - $6.95 Million
-24,897 Reduced 33.7%
48,981 $8.71 Million
Q2 2019

Aug 15, 2019

SELL
$250.96 - $284.94 $128 Million - $146 Million
-511,875 Reduced 87.39%
73,878 $19.2 Million
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $111 Million - $126 Million
441,758 Added 306.79%
585,753 $15.6 Million
Q1 2019

May 14, 2019

BUY
$276.39 - $362.25 $20.4 Million - $26.7 Million
73,787 Added 105.1%
143,995 $41.1 Million
Q4 2018

Feb 14, 2019

SELL
$281.08 - $444.25 $35.4 Million - $55.9 Million
-125,806 Reduced 64.18%
70,208 $22.8 Million
Q2 2018

Aug 14, 2018

SELL
$278.07 - $446.21 $16.9 Million - $27.1 Million
-60,719 Reduced 23.65%
196,014 $80.2 Million
Q1 2018

May 15, 2018

SELL
$192.49 - $295.85 $38.1 Million - $58.5 Million
-197,706 Reduced 43.51%
256,733 $74.7 Million
Q4 2017

Feb 14, 2018

BUY
$168.78 - $199.74 $12.9 Million - $15.2 Million
76,286 Added 20.17%
454,439 $85.2 Million
Q3 2017

Nov 14, 2017

BUY
$145.39 - $168.6 $55 Million - $63.8 Million
378,153
378,153 $63.8 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.